Global Docetaxel Market 2018 - Research Report, Demand, Price, By Application, Region and Forecast to 2025

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 114   |    Publisher : e-Market Research

This report studies the global market size of Docetaxel in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Docetaxel in these regions.
This research report categorizes the global Docetaxel market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017.
Docetaxel is widely used For Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Cancer. The most proportion of Docetaxel used for Breast Cancer and the proportion in 2017 is 85%.
In 2017, the global Docetaxel market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Docetaxel market based on company, product type, application and key regions.

The various contributors involved in the value chain of Docetaxel include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Docetaxel include
    Hengrui Medicine
    Sanofi
    Qilu Pharma
    Shenzhen Main Luck Pharma
    Jiangsu Aosaikang Pharma

Market Size Split by Type
    20 mg/ml
    40 mg/ml
    60 mg/ml
Market Size Split by Application
    Breast Cancer
    Prostate Cancer
    Non-small Cell Lung Cancer
    Other

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Docetaxel market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Docetaxel market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Docetaxel manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Docetaxel with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Docetaxel submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Docetaxel are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Docetaxel market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Docetaxel Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Docetaxel Market Size Growth Rate by Type
        1.4.2 20 mg/ml
        1.4.3 40 mg/ml
        1.4.4 60 mg/ml
    1.5 Market by Application
        1.5.1 Global Docetaxel Market Size Growth Rate by Application
        1.5.2 Breast Cancer
        1.5.3 Prostate Cancer
        1.5.4 Non-small Cell Lung Cancer
        1.5.5 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Docetaxel Market Size
        2.1.1 Global Docetaxel Revenue 2016-2025
        2.1.2 Global Docetaxel Sales 2016-2025
    2.2 Docetaxel Growth Rate by Regions
        2.2.1 Global Docetaxel Sales by Regions
        2.2.2 Global Docetaxel Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Docetaxel Sales by Manufacturers
        3.1.1 Docetaxel Sales by Manufacturers
        3.1.2 Docetaxel Sales Market Share by Manufacturers
        3.1.3 Global Docetaxel Market Concentration Ratio (CR5 and HHI)
    3.2 Docetaxel Revenue by Manufacturers
        3.2.1 Docetaxel Revenue by Manufacturers (2016-2018)
        3.2.2 Docetaxel Revenue Share by Manufacturers (2016-2018)
    3.3 Docetaxel Price by Manufacturers
    3.4 Docetaxel Manufacturing Base Distribution, Product Types
        3.4.1 Docetaxel Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Docetaxel Product Category
        3.4.3 Date of International Manufacturers Enter into Docetaxel  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Docetaxel Sales by Type
    4.2 Global Docetaxel Revenue by Type
    4.3 Docetaxel Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Docetaxel Breakdown Data by Application

6 North America
    6.1 North America Docetaxel by Countries
        6.1.1 North America Docetaxel Sales by Countries
        6.1.2 North America Docetaxel Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Docetaxel by Type
    6.3 North America Docetaxel by Application
    6.4 North America Docetaxel by Company

7 Europe
    7.1 Europe Docetaxel by Countries
        7.1.1 Europe Docetaxel Sales by Countries
        7.1.2 Europe Docetaxel Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Docetaxel by Type
    7.3 Europe Docetaxel by Application
    7.4 Europe Docetaxel by Company

8 Asia Pacific
    8.1 Asia Pacific Docetaxel by Countries
        8.1.1 Asia Pacific Docetaxel Sales by Countries
        8.1.2 Asia Pacific Docetaxel Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Docetaxel by Type
    8.3 Asia Pacific Docetaxel by Application
    8.4 Asia Pacific Docetaxel by Company

9 Central & South America
    9.1 Central & South America Docetaxel by Countries
        9.1.1 Central & South America Docetaxel Sales by Countries
        9.1.2 Central & South America Docetaxel Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Docetaxel by Type
    9.3 Central & South America Docetaxel by Application
    9.4 Central & South America Docetaxel by Company

10 Middle East and Africa
    10.1 Middle East and Africa Docetaxel by Countries
        10.1.1 Middle East and Africa Docetaxel Sales by Countries
        10.1.2 Middle East and Africa Docetaxel Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Docetaxel by Type
    10.3 Middle East and Africa Docetaxel by Application
    10.4 Middle East and Africa Docetaxel by Company

11 Company Profiles
    11.1 Hengrui Medicine
        11.1.1 Hengrui Medicine Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Docetaxel
        11.1.4 Docetaxel Product Description
        11.1.5 Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Docetaxel
        11.2.4 Docetaxel Product Description
        11.2.5 Recent Development
    11.3 Qilu Pharma
        11.3.1 Qilu Pharma Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Docetaxel
        11.3.4 Docetaxel Product Description
        11.3.5 Recent Development
    11.4 Shenzhen Main Luck Pharma
        11.4.1 Shenzhen Main Luck Pharma Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Docetaxel
        11.4.4 Docetaxel Product Description
        11.4.5 Recent Development
    11.5 Jiangsu Aosaikang Pharma
        11.5.1 Jiangsu Aosaikang Pharma Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Docetaxel
        11.5.4 Docetaxel Product Description
        11.5.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Docetaxel Raw Material
        13.1.2 Docetaxel Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Docetaxel
    Figure Global Docetaxel Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Docetaxel Production Market Share by Types (Product Category) in 2017
    Figure 20 mg/ml Product Picture
    Table Major Manufacturers of 20 mg/ml
    Figure 40 mg/ml Product Picture
    Table Major Manufacturers of 40 mg/ml
    Figure 60 mg/ml Product Picture
    Table Major Manufacturers of 60 mg/ml
    Table Global Docetaxel Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Breast Cancer
    Figure Prostate Cancer
    Figure Non-small Cell Lung Cancer
    Figure Other
    Figure Docetaxel Report Years Considered
    Figure Global Docetaxel Market Size 2016-2025 (Million US$)
    Figure Global Docetaxel Sales 2016-2025 (K Units)
    Table Global Docetaxel Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Docetaxel Sales by Regions 2016-2025 (K Units)
    Table Global Docetaxel Sales Market Share by Regions 2016-2025
    Figure Global Docetaxel Sales Market Share by Regions 2016-2025
    Figure 2017 Global Docetaxel Sales Market Share by Regions
    Table Global Docetaxel Revenue by Regions 2016-2025 (Million US$)
    Table Global Docetaxel Revenue Market Share by Regions 2016-2025
    Figure Global Docetaxel Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Docetaxel Revenue Market Share by Regions
    Table Global Docetaxel Sales by Manufacturers (2016-2018) (K Units)
    Table Global Docetaxel Sales Share by Manufacturers (2016-2018)
    Figure Global Docetaxel Sales Share by Manufacturers in 2017
    Table Docetaxel Revenue by Manufacturers (2016-2018) (Million US$)
    Table Docetaxel Revenue Share by Manufacturers (2016-2018)
    Figure Docetaxel Value Share by Manufacturers in 2017
    Table Global Docetaxel Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Docetaxel Price (2016-2018) (USD/Unit)
    Table Docetaxel Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Docetaxel Product Category
    Table Date of International Manufacturers Enter into Docetaxel Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Docetaxel Sales by Type (2016-2025) (K Units)
    Table Global Docetaxel Sales Share by Type (2016-2025)
    Figure Global Docetaxel Sales Market Share by Type (2016-2025)
    Figure Global Docetaxel Sales Market Share by Type in 2017
    Table Global Docetaxel Revenue by Type (2016-2025) (Million US$)
    Table Global Docetaxel Revenue Share by Type (2016-2025)
    Figure Global Docetaxel Revenue Market Share by Type (2016-2025)
    Figure Global Docetaxel Revenue Market Share by Type in 2017
    Table Docetaxel Price by Type 2013-2018 (USD/Unit)
    Table Global Docetaxel Sales by Application (2016-2025) (K Units)
    Table Global Docetaxel Sales Share by Application (2016-2025)
    Figure Global Sales Docetaxel Market Share by Application (2016-2025)
    Figure Global Sales Docetaxel Market Share by Application (2016-2025)
    Figure North America Docetaxel Sales Growth Rate 2016-2025 (K Units)
    Figure North America Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Docetaxel Sales by Countries (2016-2025) (K Units)
    Table North America Docetaxel Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Docetaxel Sales Market Share by Countries
    Table North America Docetaxel Revenue by Countries (2016-2025) (Million US$)
    Table North America Docetaxel Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Docetaxel Revenue Market Share by Countries
    Figure United States Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure United States Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Docetaxel Sales by Type (2016-2025) (K Units)
    Table North America Docetaxel Sales Market Share by Type (2016-2025)
    Figure 2017 North America Docetaxel Market Share by Type
    Table North America Docetaxel Sales by Application (2016-2025) (K Units)
    Table North America Docetaxel Sales Market Share by Application (2016-2025)
    Figure 2017 North America Docetaxel Market Share by Application
    Table North America Docetaxel Sales by Company (2016-2018) (K Units)
    Table North America Docetaxel Sales Market Share by Company (2016-2018)
    Figure North America Docetaxel Sales Market Share by Company in 2017
    Figure Europe Docetaxel Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Docetaxel Sales by Countries (2016-2025) (K Units)
    Table Europe Docetaxel Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Docetaxel Sales Market Share by Countries
    Table Europe Docetaxel Revenue by Countries (2016-2025) (Million US$)
    Table Europe Docetaxel Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Docetaxel Revenue Market Share by Countries
    Figure Germany Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Docetaxel Revenue Growth Rate (2016-2025) (K Units)
    Figure France Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure France Docetaxel Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure UK Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Docetaxel Sales by Type (2016-2025) (K Units)
    Table Europe Docetaxel Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Docetaxel Market Share by Type
    Table Europe Docetaxel Sales by Application (2016-2025) (K Units)
    Table Europe Docetaxel Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Docetaxel Market Share by Application
    Table Europe Docetaxel Sales by Company (2016-2018) (K Units)
    Table Europe Docetaxel Sales Market Share by Company (2016-2018)
    Figure Europe Docetaxel Sales Market Share by Company in 2017
    Figure Asia Pacific Docetaxel Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Docetaxel Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Docetaxel Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Docetaxel Sales Market Share by Countries
    Table Asia Pacific Docetaxel Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Docetaxel Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Docetaxel Revenue Market Share by Countries
    Figure China Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure China Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure India Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Docetaxel Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Docetaxel Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Docetaxel Market Share by Type
    Table Asia Pacific Docetaxel Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Docetaxel Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Docetaxel Market Share by Application
    Table Asia Pacific Docetaxel Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Docetaxel Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Docetaxel Sales Market Share by Company in 2017
    Figure Central & South America Docetaxel Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Docetaxel Sales by Countries (2016-2025) (K Units)
    Table Central & South America Docetaxel Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Docetaxel Sales Market Share by Countries
    Table Central & South America Docetaxel Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Docetaxel Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Docetaxel Revenue Market Share by Countries
    Figure Brazil Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Docetaxel Sales by Type (2016-2025) (K Units)
    Table Central & South America Docetaxel Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Docetaxel Market Share by Type
    Table Central & South America Docetaxel Sales by Application (2016-2025) (K Units)
    Table Central & South America Docetaxel Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Docetaxel Market Share by Application
    Table Central & South America Docetaxel Sales by Company (2016-2018) (K Units)
    Table Central & South America Docetaxel Sales Market Share by Company (2016-2018)
    Figure Central & South America Docetaxel Sales Market Share by Company in 2017
    Figure Middle East and Africa Docetaxel Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Docetaxel Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Docetaxel Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Docetaxel Sales Market Share by Countries
    Table Middle East and Africa Docetaxel Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Docetaxel Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Docetaxel Revenue Market Share by Countries
    Figure GCC Countries Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Docetaxel Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Docetaxel Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Docetaxel Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Docetaxel Market Share by Type
    Table Middle East and Africa Docetaxel Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Docetaxel Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Docetaxel Market Share by Application
    Table Middle East and Africa Docetaxel Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Docetaxel Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Docetaxel Sales Market Share by Company in 2017
    Table Hengrui Medicine Company Details
    Table Hengrui Medicine Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Hengrui Medicine Recent Development
    Table Sanofi Company Details
    Table Sanofi Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sanofi Recent Development
    Table Qilu Pharma Company Details
    Table Qilu Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Qilu Pharma Recent Development
    Table Shenzhen Main Luck Pharma Company Details
    Table Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Shenzhen Main Luck Pharma Recent Development
    Table Jiangsu Aosaikang Pharma Company Details
    Table Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Jiangsu Aosaikang Pharma Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Docetaxel Value Chain
    Table Typical Suppliers of Key Docetaxel Raw Material
    Table Docetaxel Customers List
    Table Docetaxel Sales Channels
    Table Docetaxel Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@e-marketresearch.com